Statement of Ownership (sc 13g)
January 20 2021 - 1:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
Helius Medical Technologies, Inc.
|
(Name of Issuer)
|
|
Class A Common Stock, $0.001 par value
|
(Title of Class of Securities)
|
|
42328V504
|
(CUSIP Number)
|
|
October 23, 2020
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
o
|
Rule 13d-1(b)
|
x
|
Rule 13d-1(c)
|
o
|
Rule 13d-1(d)
|
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 42328V504
|
13G
|
Page 1 of 6 Pages
|
1.
|
NAME OF REPORTING PERSONS
Columbus Capital Partners, L.P.
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)
(a) o
(b) o
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
California
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5.
|
SOLE VOTING POWER
0
|
6.
|
SHARED VOTING POWER
3,238,228 (See Note 1)
|
7.
|
SOLE DISPOSITIVE POWER
0
|
8.
|
SHARED DISPOSITIVE POWER
3,238,228 (See Note 1)
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,238,228 (See Note 1)
|
10.
|
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o
|
11.
|
6.2% (See Note 1)
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
|
|
|
|
|
(1)
|
This amount comprises ownership of 3,238,228 shares of Common Stock which consists of (i) 1,738,228 shares of Common Stock and (ii) 1,000,000 shares of restricted Common Stock and (iii) 500,000 shares of Common Stock issuable upon exercise of a warrant held by Columbus Capital Partners, L.P. (the "Warrant").
All such shares of Common Stock in the aggregate represent beneficial ownership of 6.2% of the Common Stock, based on (i) 51,922,480 outstanding shares of Common Stock (as defined in Item 2(d) below) as of November 6, 2020, as represented by the Issuer in the 10-Q filed
with the Securities and Exchange Commission on November 12, 2020 plus (ii) 500,000 shares of Common Stock issuable upon exercise of the Warrant.
|
CUSIP No. 42328V504
|
13G
|
Page 2 of 6 Pages
|
|
Item 1(a).
|
Name of Issuer:
|
Helius Medical Technologies, Inc. (the “Issuer”)
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
642 Newtown Yardley Rd., Suite 100
Newtown, PA 18940
|
Item 2(a).
|
Name of Persons Filing:
|
|
Columbus Capital Partners, L.P.
|
|
Item 2(b).
|
Address of Principal Business Office or, if none, Residence:
|
|
Columbus Capital Partners, L.P.
|
102 Via Los Altos
Tiburon, CA 94920
|
Columbus Capital Partners, L.P. – CA
|
|
Item 2(d).
|
Title of Class of Securities:
|
Class A Common Stock, $0.001 par value (“Common Stock”)
42328V504
|
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check
whether the person filing is a:
|
Not Applicable
CUSIP No. 42328V504
|
|
13G
|
|
Page 3 of 6 Pages
|
|
|
Columbus Capital Partners, L.P.
|
|
(a)
|
Amount beneficially owned: 3,238,228 (See Note 2)
|
|
(b)
|
Percent of class: 6.2% (See Note 2)
|
|
(c)
|
Number of shares as to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 3,238,228 (See Note 2)
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
0
|
|
(iv)
|
Shared power to dispose or to direct the disposition
of: 3,238,228 (See Note 2)
|
CUSIP No. 42328V504
|
|
13G
|
|
Page 4 of 6 Pages
|
Note 2:
This amount comprises ownership of 3,238,228 shares of Common Stock which consists of (i) 1,738,228 shares of Common Stock and (ii) 1,000,000 shares of restricted Common Stock and (iii) 500,000 shares of Common Stock issuable upon exercise of a warrant held by Columbus Capital Partners, L.P. (the "Warrant").
All such shares of Common Stock in the aggregate represent beneficial ownership of 6.2% of the Common Stock, based on (i) 51,922,480 outstanding shares of Common Stock (as defined in Item 2(d) below) as of November 6, 2020, as represented by the Issuer in the 10-Q filed
with the Securities and Exchange Commission on November 12, 2020 plus (ii) 500,000 shares of Common Stock issuable upon exercise of the Warrant.
|
Item 5.
|
Ownership of Five Percent or Less of a Class:
|
Not Applicable.
|
Item 6.
|
Ownership of More Than Five Percent on Behalf of Another Person:
|
Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding
Company:
|
Not Applicable
|
Item 8.
|
Identification and Classification of Members of the Group:
|
Not
Applicable.
|
Item 9.
|
Notice of Dissolution of Group:
|
Not
Applicable.
CUSIP No. 42328V504
|
|
13G
|
|
Page 5 of 6 Pages
|
Each
of the Reporting Persons makes the following certification:
By
signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above
were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information
set forth in this statement is true, complete and correct.
Date: January 20, 2021
COLUMBUS CAPITAL PARTNERS, L.P.
By: /s/ Matthew D. Ockner
Name: Matthew D. Ockner
Title: Managing Member
CUSIP No. 42328V504
|
|
13G
|
|
Page 6 of 6 Pages
|
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Sep 2023 to Sep 2024